▶ 調査レポート

世界の破傷風市場予測(~2028年):一価破傷風トキソイド(TT)、ジフテリア、百日咳(DTaP)、ジフテリア&破傷風(DT)

• 英文タイトル:Global Tetanus Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

GlobalInfoResearchが調査・発行した産業分析レポートです。世界の破傷風市場予測(~2028年):一価破傷風トキソイド(TT)、ジフテリア、百日咳(DTaP)、ジフテリア&破傷風(DT) / Global Tetanus Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028 / GIR-22E8973資料のイメージです。• レポートコード:GIR-22E8973
• 出版社/出版日:GlobalInfoResearch / 2022年5月
• レポート形態:英文、PDF、112ページ
• 納品方法:Eメール(2~3営業日)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥522,000 (USD3,480)▷ お問い合わせ
  Multi User¥783,000 (USD5,220)▷ お問い合わせ
  Corporate User¥1,044,000 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
破傷風市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の破傷風の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。

破傷風市場は種類と用途によって区分されます。2017年~2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・一価破傷風トキソイド(TT)、ジフテリア、百日咳(DTaP)、ジフテリア&破傷風(DT)

用途別セグメントは次のように区分されます。
・病院、診療所、政府、研究機関、その他

世界の破傷風市場の主要な市場プレーヤーは以下のとおりです。
・GlaxoSmithKline、Merck、Pfizer、Sanofi Pasteur、AstraZeneca、Bharat Biotech、Roche、Novartis、MSD、Shenzhen Kangtai Biological Products、Bausch Health、Emergent Biosolutions、Astellas Pharma、Panacea Biotec、Shanghai Fuhong Hanlin Biopharmaceutical、Suzhou Shengdia Biomedical Co. LTD、Baitai Biological Pharmaceutical Co. LTD

地域別セグメントは次の地域・国をカバーします。
・北米(米国、カナダ、メキシコ)
・ヨーロッパ(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南アメリカ(ブラジル、アルゼンチン、コロンビア)
・中東およびアフリカ(サウジアラビア、UAE、エジプト、南アフリカ)

本調査レポートの内容は計15章あります。
・第1章では、破傷風製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な破傷風メーカーの企業概要、2019年~2022年までの破傷風の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な破傷風メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年~2028年までの地域別破傷風の販売量、売上、成長性を示しています。
・第5、6章では、2017年~2028年までの破傷風の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2028年までの主要地域での破傷風市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および破傷風の産業チェーンを掲載しています。
・第13、14、15章では、破傷風の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報(企業概要、製品概要、販売量、価格、売上):GlaxoSmithKline、Merck、Pfizer、Sanofi Pasteur、AstraZeneca、Bharat Biotech、Roche、Novartis、MSD、Shenzhen Kangtai Biological Products、Bausch Health、Emergent Biosolutions、Astellas Pharma、Panacea Biotec、Shanghai Fuhong Hanlin Biopharmaceutical、Suzhou Shengdia Biomedical Co. LTD、Baitai Biological Pharmaceutical Co. LTD
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年:一価破傷風トキソイド(TT)、ジフテリア、百日咳(DTaP)、ジフテリア&破傷風(DT)
・用途別分析2017年-2028年:病院、診療所、政府、研究機関、その他
・破傷風の北米市場規模2017年-2028年:アメリカ、カナダ、メキシコ
・破傷風のヨーロッパ市場規模2017年-2028年:ドイツ、イギリス、フランス、ロシア、イタリア
・破傷風のアジア市場規模2017年-2028年:中国、日本、韓国、インド、東南アジア、オーストラリア
・破傷風の南米市場規模2017年-2028年:ブラジル、アルゼンチン
・破傷風の中東・アフリカ市場規模2017年-2028年:サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Tetanus market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Tetanus market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Tetanus global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Monovalent Tetanus Toxoid (TT) segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Tetanus include GlaxoSmithKline, Merck, Pfizer, Sanofi Pasteur, and AstraZeneca, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Tetanus market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Monovalent Tetanus Toxoid (TT)
Diphtheria
Pertussis (DTaP)
Diphtheria and Tetanus (DT)
Market segment by Application can be divided into
Hospitals
Clinics
Government
Research Organizations
Others
The key market players for global Tetanus market are listed below:
GlaxoSmithKline
Merck
Pfizer
Sanofi Pasteur
AstraZeneca
Bharat Biotech
Roche
Novartis
MSD
Shenzhen Kangtai Biological Products
Bausch Health
Emergent Biosolutions
Astellas Pharma
Panacea Biotec
Shanghai Fuhong Hanlin Biopharmaceutical
Suzhou Shengdia Biomedical Co. LTD
Baitai Biological Pharmaceutical Co. LTD
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Tetanus product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Tetanus, with price, sales, revenue and global market share of Tetanus from 2019 to 2022.
Chapter 3, the Tetanus competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tetanus breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Tetanus market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Tetanus.
Chapter 13, 14, and 15, to describe Tetanus sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Tetanus Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Tetanus Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Monovalent Tetanus Toxoid (TT)
1.2.3 Diphtheria
1.2.4 Pertussis (DTaP)
1.2.5 Diphtheria and Tetanus (DT)
1.3 Market Analysis by Application
1.3.1 Overview: Global Tetanus Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Government
1.3.5 Research Organizations
1.3.6 Others
1.4 Global Tetanus Market Size & Forecast
1.4.1 Global Tetanus Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Tetanus Sales in Volume (2017-2028)
1.4.3 Global Tetanus Price (2017-2028)
1.5 Global Tetanus Production Capacity Analysis
1.5.1 Global Tetanus Total Production Capacity (2017-2028)
1.5.2 Global Tetanus Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Tetanus Market Drivers
1.6.2 Tetanus Market Restraints
1.6.3 Tetanus Trends Analysis
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business
2.1.3 GlaxoSmithKline Tetanus Product and Services
2.1.4 GlaxoSmithKline Tetanus Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Tetanus Product and Services
2.2.4 Merck Tetanus Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Tetanus Product and Services
2.3.4 Pfizer Tetanus Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Sanofi Pasteur
2.4.1 Sanofi Pasteur Details
2.4.2 Sanofi Pasteur Major Business
2.4.3 Sanofi Pasteur Tetanus Product and Services
2.4.4 Sanofi Pasteur Tetanus Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 AstraZeneca
2.5.1 AstraZeneca Details
2.5.2 AstraZeneca Major Business
2.5.3 AstraZeneca Tetanus Product and Services
2.5.4 AstraZeneca Tetanus Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Bharat Biotech
2.6.1 Bharat Biotech Details
2.6.2 Bharat Biotech Major Business
2.6.3 Bharat Biotech Tetanus Product and Services
2.6.4 Bharat Biotech Tetanus Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Roche
2.7.1 Roche Details
2.7.2 Roche Major Business
2.7.3 Roche Tetanus Product and Services
2.7.4 Roche Tetanus Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Novartis
2.8.1 Novartis Details
2.8.2 Novartis Major Business
2.8.3 Novartis Tetanus Product and Services
2.8.4 Novartis Tetanus Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 MSD
2.9.1 MSD Details
2.9.2 MSD Major Business
2.9.3 MSD Tetanus Product and Services
2.9.4 MSD Tetanus Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Shenzhen Kangtai Biological Products
2.10.1 Shenzhen Kangtai Biological Products Details
2.10.2 Shenzhen Kangtai Biological Products Major Business
2.10.3 Shenzhen Kangtai Biological Products Tetanus Product and Services
2.10.4 Shenzhen Kangtai Biological Products Tetanus Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Bausch Health
2.11.1 Bausch Health Details
2.11.2 Bausch Health Major Business
2.11.3 Bausch Health Tetanus Product and Services
2.11.4 Bausch Health Tetanus Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Emergent Biosolutions
2.12.1 Emergent Biosolutions Details
2.12.2 Emergent Biosolutions Major Business
2.12.3 Emergent Biosolutions Tetanus Product and Services
2.12.4 Emergent Biosolutions Tetanus Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Astellas Pharma
2.13.1 Astellas Pharma Details
2.13.2 Astellas Pharma Major Business
2.13.3 Astellas Pharma Tetanus Product and Services
2.13.4 Astellas Pharma Tetanus Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Panacea Biotec
2.14.1 Panacea Biotec Details
2.14.2 Panacea Biotec Major Business
2.14.3 Panacea Biotec Tetanus Product and Services
2.14.4 Panacea Biotec Tetanus Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Shanghai Fuhong Hanlin Biopharmaceutical
2.15.1 Shanghai Fuhong Hanlin Biopharmaceutical Details
2.15.2 Shanghai Fuhong Hanlin Biopharmaceutical Major Business
2.15.3 Shanghai Fuhong Hanlin Biopharmaceutical Tetanus Product and Services
2.15.4 Shanghai Fuhong Hanlin Biopharmaceutical Tetanus Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Suzhou Shengdia Biomedical Co. LTD
2.16.1 Suzhou Shengdia Biomedical Co. LTD Details
2.16.2 Suzhou Shengdia Biomedical Co. LTD Major Business
2.16.3 Suzhou Shengdia Biomedical Co. LTD Tetanus Product and Services
2.16.4 Suzhou Shengdia Biomedical Co. LTD Tetanus Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Baitai Biological Pharmaceutical Co. LTD
2.17.1 Baitai Biological Pharmaceutical Co. LTD Details
2.17.2 Baitai Biological Pharmaceutical Co. LTD Major Business
2.17.3 Baitai Biological Pharmaceutical Co. LTD Tetanus Product and Services
2.17.4 Baitai Biological Pharmaceutical Co. LTD Tetanus Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Tetanus Breakdown Data by Manufacturer
3.1 Global Tetanus Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Tetanus Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Tetanus
3.4 Market Concentration Rate
3.4.1 Top 3 Tetanus Manufacturer Market Share in 2021
3.4.2 Top 6 Tetanus Manufacturer Market Share in 2021
3.5 Global Tetanus Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Tetanus Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Tetanus Market Size by Region
4.1.1 Global Tetanus Sales in Volume by Region (2017-2028)
4.1.2 Global Tetanus Revenue by Region (2017-2028)
4.2 North America Tetanus Revenue (2017-2028)
4.3 Europe Tetanus Revenue (2017-2028)
4.4 Asia-Pacific Tetanus Revenue (2017-2028)
4.5 South America Tetanus Revenue (2017-2028)
4.6 Middle East and Africa Tetanus Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Tetanus Sales in Volume by Type (2017-2028)
5.2 Global Tetanus Revenue by Type (2017-2028)
5.3 Global Tetanus Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Tetanus Sales in Volume by Application (2017-2028)
6.2 Global Tetanus Revenue by Application (2017-2028)
6.3 Global Tetanus Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Tetanus Sales by Type (2017-2028)
7.2 North America Tetanus Sales by Application (2017-2028)
7.3 North America Tetanus Market Size by Country
7.3.1 North America Tetanus Sales in Volume by Country (2017-2028)
7.3.2 North America Tetanus Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Tetanus Sales by Type (2017-2028)
8.2 Europe Tetanus Sales by Application (2017-2028)
8.3 Europe Tetanus Market Size by Country
8.3.1 Europe Tetanus Sales in Volume by Country (2017-2028)
8.3.2 Europe Tetanus Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Tetanus Sales by Type (2017-2028)
9.2 Asia-Pacific Tetanus Sales by Application (2017-2028)
9.3 Asia-Pacific Tetanus Market Size by Region
9.3.1 Asia-Pacific Tetanus Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Tetanus Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Tetanus Sales by Type (2017-2028)
10.2 South America Tetanus Sales by Application (2017-2028)
10.3 South America Tetanus Market Size by Country
10.3.1 South America Tetanus Sales in Volume by Country (2017-2028)
10.3.2 South America Tetanus Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Tetanus Sales by Type (2017-2028)
11.2 Middle East & Africa Tetanus Sales by Application (2017-2028)
11.3 Middle East & Africa Tetanus Market Size by Country
11.3.1 Middle East & Africa Tetanus Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Tetanus Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Tetanus and Key Manufacturers
12.2 Manufacturing Costs Percentage of Tetanus
12.3 Tetanus Production Process
12.4 Tetanus Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Tetanus Typical Distributors
13.3 Tetanus Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer